Cardinal Health (CAH) Earns Daily Media Impact Rating of 0.15
Media headlines about Cardinal Health (NYSE:CAH) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave press coverage about the company an impact score of 46.627674125782 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Cardinal Health, Inc. (CAH) Ownership Up in Latest Report from Norges Bank – Modern Readers (modernreaders.com)
- Cardinal Health, Inc. to Issue Quarterly Dividend of $0.46 (CAH) (americanbankingnews.com)
- Texas Permanent School Fund Reduces Stake in Cardinal Health, Inc. (CAH) – ExpressNewsline (expressnewsline.com)
- Cardinal Health, Inc. (CAH) registers a price change of 0.14% while ServiceMaster Global Holdings, Inc. (SERV … – Stocks Gallery (stocksgallery.com)
- Shareholders Can’t Force Pharmaceutical Company To Prove Drugs Aren’t Used For Executions (ibtimes.com)
Several research analysts have commented on CAH shares. Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Credit Suisse Group reissued a “buy” rating and set a $81.00 price objective on shares of Cardinal Health in a report on Tuesday, May 2nd. William Blair downgraded shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 19th. Tigress Financial started coverage on shares of Cardinal Health in a report on Friday, April 28th. They set a “neutral” rating for the company. Finally, Jefferies Group LLC started coverage on shares of Cardinal Health in a report on Wednesday, May 17th. They set a “hold” rating and a $77.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the stock. Cardinal Health currently has a consensus rating of “Hold” and an average price target of $80.46.
Cardinal Health (NYSE:CAH) opened at 68.23 on Thursday. Cardinal Health has a 52 week low of $62.70 and a 52 week high of $84.88. The company has a market capitalization of $21.56 billion, a P/E ratio of 16.93 and a beta of 0.80. The firm has a 50-day moving average of $76.89 and a 200-day moving average of $77.11.
Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.14 EPS. Analysts anticipate that Cardinal Health will post $5.00 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be paid a dividend of $0.4624 per share. This represents a $1.85 annualized dividend and a yield of 2.71%. Cardinal Health’s payout ratio is currently 45.79%.
In related news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The shares were sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the sale, the insider now directly owns 55,440 shares of the company’s stock, valued at approximately $4,039,912.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.94% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/10/cardinal-health-cah-earns-daily-media-impact-rating-of-0-15.html.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.